nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—ACHE—Physostigmine—glaucoma	0.214	0.29	CbGbCtD
Donepezil—ACHE—Echothiophate—glaucoma	0.214	0.29	CbGbCtD
Donepezil—ACHE—Dipivefrin—glaucoma	0.13	0.176	CbGbCtD
Donepezil—CYP2D6—Carteolol—glaucoma	0.0262	0.0355	CbGbCtD
Donepezil—CYP2D6—Betaxolol—glaucoma	0.0177	0.024	CbGbCtD
Donepezil—CYP2C9—Diclofenamide—glaucoma	0.0171	0.0231	CbGbCtD
Donepezil—CYP2C9—Dorzolamide—glaucoma	0.0165	0.0223	CbGbCtD
Donepezil—CYP2C9—Methazolamide—glaucoma	0.0147	0.0199	CbGbCtD
Donepezil—CYP2D6—Methazolamide—glaucoma	0.0134	0.0182	CbGbCtD
Donepezil—CYP3A4—Pilocarpine—glaucoma	0.0126	0.0171	CbGbCtD
Donepezil—CYP2D6—Timolol—glaucoma	0.0114	0.0155	CbGbCtD
Donepezil—CYP3A4—Brinzolamide—glaucoma	0.00992	0.0134	CbGbCtD
Donepezil—CYP2D6—Clonidine—glaucoma	0.00971	0.0131	CbGbCtD
Donepezil—CYP3A4—Dorzolamide—glaucoma	0.00958	0.013	CbGbCtD
Donepezil—CYP3A4—Methazolamide—glaucoma	0.00854	0.0116	CbGbCtD
Donepezil—CYP3A4—Acetazolamide—glaucoma	0.00683	0.00924	CbGbCtD
Donepezil—CYP3A4—Clonidine—glaucoma	0.00617	0.00836	CbGbCtD
Donepezil—Moexipril—ACE2—glaucoma	0.00512	1	CrCbGaD
Donepezil—ACHE—Melatonin metabolism and effects—CYP1B1—glaucoma	0.00025	0.0208	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000245	0.0204	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000242	0.0201	CbGpPWpGaD
Donepezil—ACHE—Peptide hormone metabolism—ACE2—glaucoma	0.000236	0.0197	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000221	0.0184	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00021	0.0175	CbGpPWpGaD
Donepezil—ACHE—Melatonin metabolism and effects—EDN1—glaucoma	0.000202	0.0168	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.000197	0.0164	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000189	0.0158	CbGpPWpGaD
Donepezil—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000171	0.0142	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Other—PTGFR—glaucoma	0.000168	0.014	CbGpPWpGaD
Donepezil—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000167	0.0139	CbGpPWpGaD
Donepezil—ACHE—ATF-2 transcription factor network—TGFB2—glaucoma	0.000166	0.0138	CbGpPWpGaD
Donepezil—ACHE—Melatonin metabolism and effects—APOE—glaucoma	0.000164	0.0137	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—OPN4—glaucoma	0.00016	0.0133	CbGpPWpGaD
Donepezil—HRH3—Monoamine Transport—TNF—glaucoma	0.000147	0.0122	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—PTGFR—glaucoma	0.000144	0.012	CbGpPWpGaD
Donepezil—CYP2D6—Tamoxifen metabolism—CYP1B1—glaucoma	0.000133	0.011	CbGpPWpGaD
Donepezil—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	0.000131	0.0109	CbGpPWpGaD
Donepezil—ACHE—Peptide hormone metabolism—PAX6—glaucoma	0.000126	0.0105	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—OPN4—glaucoma	0.000105	0.00875	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000105	0.00874	CbGpPWpGaD
Donepezil—CYP2D6—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000102	0.00852	CbGpPWpGaD
Donepezil—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	9.81e-05	0.00816	CbGpPWpGaD
Donepezil—Dyspnoea—Pilocarpine—glaucoma	9.66e-05	0.000396	CcSEcCtD
Donepezil—Pain—Brinzolamide—glaucoma	9.64e-05	0.000395	CcSEcCtD
Donepezil—Somnolence—Pilocarpine—glaucoma	9.63e-05	0.000395	CcSEcCtD
Donepezil—Depression—Timolol—glaucoma	9.62e-05	0.000394	CcSEcCtD
Donepezil—Pruritus—Bimatoprost—glaucoma	9.6e-05	0.000393	CcSEcCtD
Donepezil—Diarrhoea—Apraclonidine—glaucoma	9.57e-05	0.000392	CcSEcCtD
Donepezil—ACHE—ATF-2 transcription factor network—BCL2L1—glaucoma	9.57e-05	0.00796	CbGpPWpGaD
Donepezil—Malaise—Clonidine—glaucoma	9.56e-05	0.000392	CcSEcCtD
Donepezil—Dyspepsia—Pilocarpine—glaucoma	9.54e-05	0.000391	CcSEcCtD
Donepezil—Chills—Betaxolol—glaucoma	9.52e-05	0.00039	CcSEcCtD
Donepezil—Syncope—Clonidine—glaucoma	9.51e-05	0.000389	CcSEcCtD
Donepezil—Arrhythmia—Betaxolol—glaucoma	9.47e-05	0.000388	CcSEcCtD
Donepezil—HTR2A—G alpha (q) signalling events—PTGFR—glaucoma	9.46e-05	0.00788	CbGpPWpGaD
Donepezil—Feeling abnormal—Dorzolamide—glaucoma	9.45e-05	0.000387	CcSEcCtD
Donepezil—Decreased appetite—Pilocarpine—glaucoma	9.42e-05	0.000386	CcSEcCtD
Donepezil—Feeling abnormal—Travoprost—glaucoma	9.41e-05	0.000385	CcSEcCtD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	9.4e-05	0.00782	CbGpPWpGaD
Donepezil—Conjunctivitis—Timolol—glaucoma	9.38e-05	0.000384	CcSEcCtD
Donepezil—Gastrointestinal pain—Dorzolamide—glaucoma	9.38e-05	0.000384	CcSEcCtD
Donepezil—Alopecia—Betaxolol—glaucoma	9.37e-05	0.000384	CcSEcCtD
Donepezil—Gastrointestinal disorder—Pilocarpine—glaucoma	9.36e-05	0.000383	CcSEcCtD
Donepezil—Gastrointestinal pain—Travoprost—glaucoma	9.34e-05	0.000382	CcSEcCtD
Donepezil—Loss of consciousness—Clonidine—glaucoma	9.32e-05	0.000382	CcSEcCtD
Donepezil—Feeling abnormal—Brinzolamide—glaucoma	9.29e-05	0.000381	CcSEcCtD
Donepezil—Mental disorder—Betaxolol—glaucoma	9.29e-05	0.000381	CcSEcCtD
Donepezil—Pain—Pilocarpine—glaucoma	9.27e-05	0.00038	CcSEcCtD
Donepezil—Constipation—Pilocarpine—glaucoma	9.27e-05	0.00038	CcSEcCtD
Donepezil—Cough—Clonidine—glaucoma	9.25e-05	0.000379	CcSEcCtD
Donepezil—Sweating—Timolol—glaucoma	9.25e-05	0.000379	CcSEcCtD
Donepezil—Dizziness—Apraclonidine—glaucoma	9.25e-05	0.000379	CcSEcCtD
Donepezil—Malnutrition—Betaxolol—glaucoma	9.23e-05	0.000378	CcSEcCtD
Donepezil—Erythema—Betaxolol—glaucoma	9.23e-05	0.000378	CcSEcCtD
Donepezil—Urticaria—Dorzolamide—glaucoma	9.11e-05	0.000373	CcSEcCtD
Donepezil—Epistaxis—Timolol—glaucoma	9.1e-05	0.000373	CcSEcCtD
Donepezil—Abdominal pain—Dorzolamide—glaucoma	9.07e-05	0.000371	CcSEcCtD
Donepezil—Body temperature increased—Dorzolamide—glaucoma	9.07e-05	0.000371	CcSEcCtD
Donepezil—Tension—Betaxolol—glaucoma	9.06e-05	0.000371	CcSEcCtD
Donepezil—HRH3—GPCR downstream signaling—OPN4—glaucoma	9.05e-05	0.00753	CbGpPWpGaD
Donepezil—Dysgeusia—Betaxolol—glaucoma	9.04e-05	0.00037	CcSEcCtD
Donepezil—Arthralgia—Clonidine—glaucoma	9.03e-05	0.00037	CcSEcCtD
Donepezil—Chest pain—Clonidine—glaucoma	9.03e-05	0.00037	CcSEcCtD
Donepezil—Abdominal pain—Travoprost—glaucoma	9.03e-05	0.00037	CcSEcCtD
Donepezil—Anxiety—Clonidine—glaucoma	9e-05	0.000368	CcSEcCtD
Donepezil—Asthenia—Acetazolamide—glaucoma	8.98e-05	0.000368	CcSEcCtD
Donepezil—Dizziness—Bimatoprost—glaucoma	8.97e-05	0.000367	CcSEcCtD
Donepezil—Nervousness—Betaxolol—glaucoma	8.97e-05	0.000367	CcSEcCtD
Donepezil—Urticaria—Brinzolamide—glaucoma	8.96e-05	0.000367	CcSEcCtD
Donepezil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	8.94e-05	0.00744	CbGpPWpGaD
Donepezil—Feeling abnormal—Pilocarpine—glaucoma	8.93e-05	0.000366	CcSEcCtD
Donepezil—Discomfort—Clonidine—glaucoma	8.92e-05	0.000365	CcSEcCtD
Donepezil—Vomiting—Apraclonidine—glaucoma	8.89e-05	0.000364	CcSEcCtD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	8.88e-05	0.00739	CbGpPWpGaD
Donepezil—Muscle spasms—Betaxolol—glaucoma	8.88e-05	0.000364	CcSEcCtD
Donepezil—Gastrointestinal pain—Pilocarpine—glaucoma	8.86e-05	0.000363	CcSEcCtD
Donepezil—Hypersensitivity—Brimonidine—glaucoma	8.85e-05	0.000362	CcSEcCtD
Donepezil—Dry mouth—Clonidine—glaucoma	8.83e-05	0.000362	CcSEcCtD
Donepezil—Bradycardia—Timolol—glaucoma	8.82e-05	0.000361	CcSEcCtD
Donepezil—Dermatitis—Apraclonidine—glaucoma	8.81e-05	0.000361	CcSEcCtD
Donepezil—Headache—Apraclonidine—glaucoma	8.76e-05	0.000359	CcSEcCtD
Donepezil—Confusional state—Clonidine—glaucoma	8.73e-05	0.000357	CcSEcCtD
Donepezil—Vision blurred—Betaxolol—glaucoma	8.7e-05	0.000356	CcSEcCtD
Donepezil—Rhinitis—Timolol—glaucoma	8.69e-05	0.000356	CcSEcCtD
Donepezil—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	8.67e-05	0.00722	CbGpPWpGaD
Donepezil—Oedema—Clonidine—glaucoma	8.65e-05	0.000354	CcSEcCtD
Donepezil—Tremor—Betaxolol—glaucoma	8.65e-05	0.000354	CcSEcCtD
Donepezil—Hallucination—Timolol—glaucoma	8.62e-05	0.000353	CcSEcCtD
Donepezil—Asthenia—Brimonidine—glaucoma	8.62e-05	0.000353	CcSEcCtD
Donepezil—Infection—Clonidine—glaucoma	8.6e-05	0.000352	CcSEcCtD
Donepezil—Abdominal pain—Pilocarpine—glaucoma	8.57e-05	0.000351	CcSEcCtD
Donepezil—Body temperature increased—Pilocarpine—glaucoma	8.57e-05	0.000351	CcSEcCtD
Donepezil—Ill-defined disorder—Betaxolol—glaucoma	8.57e-05	0.000351	CcSEcCtD
Donepezil—Diarrhoea—Acetazolamide—glaucoma	8.56e-05	0.000351	CcSEcCtD
Donepezil—Rash—Bimatoprost—glaucoma	8.55e-05	0.00035	CcSEcCtD
Donepezil—Dermatitis—Bimatoprost—glaucoma	8.54e-05	0.00035	CcSEcCtD
Donepezil—Oedema peripheral—Timolol—glaucoma	8.54e-05	0.00035	CcSEcCtD
Donepezil—Anaemia—Betaxolol—glaucoma	8.53e-05	0.000349	CcSEcCtD
Donepezil—Shock—Clonidine—glaucoma	8.51e-05	0.000349	CcSEcCtD
Donepezil—Pruritus—Brimonidine—glaucoma	8.5e-05	0.000348	CcSEcCtD
Donepezil—Headache—Bimatoprost—glaucoma	8.5e-05	0.000348	CcSEcCtD
Donepezil—HTR2A—GPCRs, Other—SMO—glaucoma	8.49e-05	0.00707	CbGpPWpGaD
Donepezil—Nervous system disorder—Clonidine—glaucoma	8.49e-05	0.000348	CcSEcCtD
Donepezil—Thrombocytopenia—Clonidine—glaucoma	8.47e-05	0.000347	CcSEcCtD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	8.46e-05	0.00704	CbGpPWpGaD
Donepezil—Hypersensitivity—Dorzolamide—glaucoma	8.45e-05	0.000346	CcSEcCtD
Donepezil—Hypersensitivity—Travoprost—glaucoma	8.41e-05	0.000345	CcSEcCtD
Donepezil—Hyperhidrosis—Clonidine—glaucoma	8.37e-05	0.000343	CcSEcCtD
Donepezil—Visual impairment—Timolol—glaucoma	8.35e-05	0.000342	CcSEcCtD
Donepezil—Malaise—Betaxolol—glaucoma	8.33e-05	0.000341	CcSEcCtD
Donepezil—Nausea—Apraclonidine—glaucoma	8.31e-05	0.00034	CcSEcCtD
Donepezil—Hypersensitivity—Brinzolamide—glaucoma	8.31e-05	0.00034	CcSEcCtD
Donepezil—Vertigo—Betaxolol—glaucoma	8.29e-05	0.00034	CcSEcCtD
Donepezil—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	8.28e-05	0.00689	CbGpPWpGaD
Donepezil—Syncope—Betaxolol—glaucoma	8.28e-05	0.000339	CcSEcCtD
Donepezil—Dizziness—Acetazolamide—glaucoma	8.27e-05	0.000339	CcSEcCtD
Donepezil—Anorexia—Clonidine—glaucoma	8.25e-05	0.000338	CcSEcCtD
Donepezil—Asthenia—Dorzolamide—glaucoma	8.23e-05	0.000337	CcSEcCtD
Donepezil—HRH3—Signaling by GPCR—OPN4—glaucoma	8.21e-05	0.00684	CbGpPWpGaD
Donepezil—Asthenia—Travoprost—glaucoma	8.19e-05	0.000336	CcSEcCtD
Donepezil—HRH3—GPCR downstream signaling—PTGFR—glaucoma	8.14e-05	0.00678	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	8.12e-05	0.00676	CbGpPWpGaD
Donepezil—Pruritus—Dorzolamide—glaucoma	8.11e-05	0.000332	CcSEcCtD
Donepezil—Loss of consciousness—Betaxolol—glaucoma	8.11e-05	0.000332	CcSEcCtD
Donepezil—Asthenia—Brinzolamide—glaucoma	8.09e-05	0.000331	CcSEcCtD
Donepezil—Hypotension—Clonidine—glaucoma	8.09e-05	0.000331	CcSEcCtD
Donepezil—Pruritus—Travoprost—glaucoma	8.08e-05	0.000331	CcSEcCtD
Donepezil—Tinnitus—Timolol—glaucoma	8.08e-05	0.000331	CcSEcCtD
Donepezil—Cough—Betaxolol—glaucoma	8.06e-05	0.00033	CcSEcCtD
Donepezil—Nausea—Bimatoprost—glaucoma	8.06e-05	0.00033	CcSEcCtD
Donepezil—ACHE—Neuronal System—SLC6A13—glaucoma	8.04e-05	0.0067	CbGpPWpGaD
Donepezil—Hypersensitivity—Pilocarpine—glaucoma	7.98e-05	0.000327	CcSEcCtD
Donepezil—Pruritus—Brinzolamide—glaucoma	7.98e-05	0.000327	CcSEcCtD
Donepezil—Vomiting—Acetazolamide—glaucoma	7.96e-05	0.000326	CcSEcCtD
Donepezil—Dizziness—Brimonidine—glaucoma	7.94e-05	0.000325	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Clonidine—glaucoma	7.89e-05	0.000323	CcSEcCtD
Donepezil—Arthralgia—Betaxolol—glaucoma	7.86e-05	0.000322	CcSEcCtD
Donepezil—Myalgia—Betaxolol—glaucoma	7.86e-05	0.000322	CcSEcCtD
Donepezil—Chest pain—Betaxolol—glaucoma	7.86e-05	0.000322	CcSEcCtD
Donepezil—Diarrhoea—Dorzolamide—glaucoma	7.85e-05	0.000321	CcSEcCtD
Donepezil—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	7.84e-05	0.00653	CbGpPWpGaD
Donepezil—Headache—Acetazolamide—glaucoma	7.84e-05	0.000321	CcSEcCtD
Donepezil—Anxiety—Betaxolol—glaucoma	7.83e-05	0.000321	CcSEcCtD
Donepezil—Insomnia—Clonidine—glaucoma	7.83e-05	0.000321	CcSEcCtD
Donepezil—Diarrhoea—Travoprost—glaucoma	7.81e-05	0.00032	CcSEcCtD
Donepezil—Asthenia—Pilocarpine—glaucoma	7.78e-05	0.000318	CcSEcCtD
Donepezil—ACHE—Metabolism of proteins—DHPS—glaucoma	7.77e-05	0.00647	CbGpPWpGaD
Donepezil—Paraesthesia—Clonidine—glaucoma	7.77e-05	0.000318	CcSEcCtD
Donepezil—Discomfort—Betaxolol—glaucoma	7.77e-05	0.000318	CcSEcCtD
Donepezil—Arrhythmia—Timolol—glaucoma	7.74e-05	0.000317	CcSEcCtD
Donepezil—Dyspnoea—Clonidine—glaucoma	7.72e-05	0.000316	CcSEcCtD
Donepezil—Diarrhoea—Brinzolamide—glaucoma	7.72e-05	0.000316	CcSEcCtD
Donepezil—Somnolence—Clonidine—glaucoma	7.69e-05	0.000315	CcSEcCtD
Donepezil—Dry mouth—Betaxolol—glaucoma	7.69e-05	0.000315	CcSEcCtD
Donepezil—ACHE—Transmission across Chemical Synapses—SLC6A1—glaucoma	7.68e-05	0.0064	CbGpPWpGaD
Donepezil—Pruritus—Pilocarpine—glaucoma	7.67e-05	0.000314	CcSEcCtD
Donepezil—Alopecia—Timolol—glaucoma	7.66e-05	0.000314	CcSEcCtD
Donepezil—Confusional state—Betaxolol—glaucoma	7.6e-05	0.000311	CcSEcCtD
Donepezil—Mental disorder—Timolol—glaucoma	7.59e-05	0.000311	CcSEcCtD
Donepezil—Dizziness—Dorzolamide—glaucoma	7.58e-05	0.000311	CcSEcCtD
Donepezil—Rash—Brimonidine—glaucoma	7.57e-05	0.00031	CcSEcCtD
Donepezil—Dermatitis—Brimonidine—glaucoma	7.57e-05	0.00031	CcSEcCtD
Donepezil—Dizziness—Travoprost—glaucoma	7.55e-05	0.000309	CcSEcCtD
Donepezil—Erythema—Timolol—glaucoma	7.54e-05	0.000309	CcSEcCtD
Donepezil—Malnutrition—Timolol—glaucoma	7.54e-05	0.000309	CcSEcCtD
Donepezil—Oedema—Betaxolol—glaucoma	7.53e-05	0.000309	CcSEcCtD
Donepezil—Headache—Brimonidine—glaucoma	7.52e-05	0.000308	CcSEcCtD
Donepezil—Decreased appetite—Clonidine—glaucoma	7.52e-05	0.000308	CcSEcCtD
Donepezil—Infection—Betaxolol—glaucoma	7.49e-05	0.000307	CcSEcCtD
Donepezil—Gastrointestinal disorder—Clonidine—glaucoma	7.47e-05	0.000306	CcSEcCtD
Donepezil—Fatigue—Clonidine—glaucoma	7.46e-05	0.000306	CcSEcCtD
Donepezil—Dizziness—Brinzolamide—glaucoma	7.46e-05	0.000305	CcSEcCtD
Donepezil—ACHE—ATF-2 transcription factor network—MMP2—glaucoma	7.44e-05	0.00619	CbGpPWpGaD
Donepezil—Nausea—Acetazolamide—glaucoma	7.43e-05	0.000304	CcSEcCtD
Donepezil—Diarrhoea—Pilocarpine—glaucoma	7.42e-05	0.000304	CcSEcCtD
Donepezil—Shock—Betaxolol—glaucoma	7.41e-05	0.000304	CcSEcCtD
Donepezil—Tension—Timolol—glaucoma	7.4e-05	0.000303	CcSEcCtD
Donepezil—Pain—Clonidine—glaucoma	7.4e-05	0.000303	CcSEcCtD
Donepezil—Constipation—Clonidine—glaucoma	7.4e-05	0.000303	CcSEcCtD
Donepezil—HRH3—Signaling by GPCR—PTGFR—glaucoma	7.4e-05	0.00616	CbGpPWpGaD
Donepezil—Nervous system disorder—Betaxolol—glaucoma	7.39e-05	0.000303	CcSEcCtD
Donepezil—Dysgeusia—Timolol—glaucoma	7.39e-05	0.000303	CcSEcCtD
Donepezil—Thrombocytopenia—Betaxolol—glaucoma	7.38e-05	0.000302	CcSEcCtD
Donepezil—Nervousness—Timolol—glaucoma	7.33e-05	0.0003	CcSEcCtD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	7.31e-05	0.00609	CbGpPWpGaD
Donepezil—Vomiting—Dorzolamide—glaucoma	7.29e-05	0.000299	CcSEcCtD
Donepezil—Hyperhidrosis—Betaxolol—glaucoma	7.28e-05	0.000298	CcSEcCtD
Donepezil—HRH3—GPCR ligand binding—SMO—glaucoma	7.27e-05	0.00605	CbGpPWpGaD
Donepezil—Rash—Dorzolamide—glaucoma	7.23e-05	0.000296	CcSEcCtD
Donepezil—Dermatitis—Dorzolamide—glaucoma	7.23e-05	0.000296	CcSEcCtD
Donepezil—Rash—Travoprost—glaucoma	7.2e-05	0.000295	CcSEcCtD
Donepezil—Dermatitis—Travoprost—glaucoma	7.19e-05	0.000295	CcSEcCtD
Donepezil—Headache—Dorzolamide—glaucoma	7.19e-05	0.000294	CcSEcCtD
Donepezil—Anorexia—Betaxolol—glaucoma	7.18e-05	0.000294	CcSEcCtD
Donepezil—Vomiting—Brinzolamide—glaucoma	7.17e-05	0.000294	CcSEcCtD
Donepezil—Dizziness—Pilocarpine—glaucoma	7.17e-05	0.000294	CcSEcCtD
Donepezil—Headache—Travoprost—glaucoma	7.15e-05	0.000293	CcSEcCtD
Donepezil—Nausea—Brimonidine—glaucoma	7.13e-05	0.000292	CcSEcCtD
Donepezil—Feeling abnormal—Clonidine—glaucoma	7.13e-05	0.000292	CcSEcCtD
Donepezil—Rash—Brinzolamide—glaucoma	7.11e-05	0.000291	CcSEcCtD
Donepezil—Vision blurred—Timolol—glaucoma	7.11e-05	0.000291	CcSEcCtD
Donepezil—Dermatitis—Brinzolamide—glaucoma	7.1e-05	0.000291	CcSEcCtD
Donepezil—Gastrointestinal pain—Clonidine—glaucoma	7.08e-05	0.00029	CcSEcCtD
Donepezil—Headache—Brinzolamide—glaucoma	7.06e-05	0.000289	CcSEcCtD
Donepezil—HTR2A—SIDS Susceptibility Pathways—HDAC9—glaucoma	7.05e-05	0.00587	CbGpPWpGaD
Donepezil—Hypotension—Betaxolol—glaucoma	7.04e-05	0.000288	CcSEcCtD
Donepezil—ACHE—Monoamine Transport—TNF—glaucoma	7.02e-05	0.00584	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—LRP12—glaucoma	7e-05	0.00583	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	6.96e-05	0.00579	CbGpPWpGaD
Donepezil—HRH3—G alpha (i) signalling events—C3—glaucoma	6.91e-05	0.00575	CbGpPWpGaD
Donepezil—Vomiting—Pilocarpine—glaucoma	6.89e-05	0.000282	CcSEcCtD
Donepezil—Urticaria—Clonidine—glaucoma	6.88e-05	0.000282	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Betaxolol—glaucoma	6.86e-05	0.000281	CcSEcCtD
Donepezil—Body temperature increased—Clonidine—glaucoma	6.84e-05	0.00028	CcSEcCtD
Donepezil—Abdominal pain—Clonidine—glaucoma	6.84e-05	0.00028	CcSEcCtD
Donepezil—Rash—Pilocarpine—glaucoma	6.83e-05	0.00028	CcSEcCtD
Donepezil—Dermatitis—Pilocarpine—glaucoma	6.83e-05	0.00028	CcSEcCtD
Donepezil—Insomnia—Betaxolol—glaucoma	6.81e-05	0.000279	CcSEcCtD
Donepezil—Nausea—Dorzolamide—glaucoma	6.81e-05	0.000279	CcSEcCtD
Donepezil—Headache—Pilocarpine—glaucoma	6.79e-05	0.000278	CcSEcCtD
Donepezil—Nausea—Travoprost—glaucoma	6.78e-05	0.000278	CcSEcCtD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	6.78e-05	0.00564	CbGpPWpGaD
Donepezil—Vertigo—Timolol—glaucoma	6.78e-05	0.000278	CcSEcCtD
Donepezil—Paraesthesia—Betaxolol—glaucoma	6.77e-05	0.000277	CcSEcCtD
Donepezil—Syncope—Timolol—glaucoma	6.76e-05	0.000277	CcSEcCtD
Donepezil—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	6.74e-05	0.00561	CbGpPWpGaD
Donepezil—Dyspnoea—Betaxolol—glaucoma	6.72e-05	0.000275	CcSEcCtD
Donepezil—Nausea—Brinzolamide—glaucoma	6.7e-05	0.000274	CcSEcCtD
Donepezil—Dyspepsia—Betaxolol—glaucoma	6.63e-05	0.000272	CcSEcCtD
Donepezil—Loss of consciousness—Timolol—glaucoma	6.63e-05	0.000272	CcSEcCtD
Donepezil—Cough—Timolol—glaucoma	6.58e-05	0.00027	CcSEcCtD
Donepezil—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	6.57e-05	0.00547	CbGpPWpGaD
Donepezil—Decreased appetite—Betaxolol—glaucoma	6.55e-05	0.000268	CcSEcCtD
Donepezil—Hypertension—Timolol—glaucoma	6.51e-05	0.000267	CcSEcCtD
Donepezil—Gastrointestinal disorder—Betaxolol—glaucoma	6.51e-05	0.000266	CcSEcCtD
Donepezil—Fatigue—Betaxolol—glaucoma	6.5e-05	0.000266	CcSEcCtD
Donepezil—Constipation—Betaxolol—glaucoma	6.44e-05	0.000264	CcSEcCtD
Donepezil—Pain—Betaxolol—glaucoma	6.44e-05	0.000264	CcSEcCtD
Donepezil—Nausea—Pilocarpine—glaucoma	6.44e-05	0.000264	CcSEcCtD
Donepezil—Myalgia—Timolol—glaucoma	6.42e-05	0.000263	CcSEcCtD
Donepezil—Chest pain—Timolol—glaucoma	6.42e-05	0.000263	CcSEcCtD
Donepezil—Arthralgia—Timolol—glaucoma	6.42e-05	0.000263	CcSEcCtD
Donepezil—Anxiety—Timolol—glaucoma	6.4e-05	0.000262	CcSEcCtD
Donepezil—Hypersensitivity—Clonidine—glaucoma	6.38e-05	0.000261	CcSEcCtD
Donepezil—Discomfort—Timolol—glaucoma	6.34e-05	0.00026	CcSEcCtD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	6.29e-05	0.00524	CbGpPWpGaD
Donepezil—Dry mouth—Timolol—glaucoma	6.28e-05	0.000257	CcSEcCtD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	6.27e-05	0.00522	CbGpPWpGaD
Donepezil—Asthenia—Clonidine—glaucoma	6.21e-05	0.000254	CcSEcCtD
Donepezil—Feeling abnormal—Betaxolol—glaucoma	6.21e-05	0.000254	CcSEcCtD
Donepezil—Confusional state—Timolol—glaucoma	6.21e-05	0.000254	CcSEcCtD
Donepezil—Oedema—Timolol—glaucoma	6.16e-05	0.000252	CcSEcCtD
Donepezil—Pruritus—Clonidine—glaucoma	6.12e-05	0.000251	CcSEcCtD
Donepezil—Infection—Timolol—glaucoma	6.12e-05	0.00025	CcSEcCtD
Donepezil—Shock—Timolol—glaucoma	6.06e-05	0.000248	CcSEcCtD
Donepezil—Nervous system disorder—Timolol—glaucoma	6.04e-05	0.000247	CcSEcCtD
Donepezil—Urticaria—Betaxolol—glaucoma	5.99e-05	0.000245	CcSEcCtD
Donepezil—Body temperature increased—Betaxolol—glaucoma	5.96e-05	0.000244	CcSEcCtD
Donepezil—Hyperhidrosis—Timolol—glaucoma	5.95e-05	0.000244	CcSEcCtD
Donepezil—Diarrhoea—Clonidine—glaucoma	5.92e-05	0.000243	CcSEcCtD
Donepezil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	5.9e-05	0.00491	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—SLC6A1—glaucoma	5.89e-05	0.0049	CbGpPWpGaD
Donepezil—Anorexia—Timolol—glaucoma	5.87e-05	0.00024	CcSEcCtD
Donepezil—Hypotension—Timolol—glaucoma	5.75e-05	0.000236	CcSEcCtD
Donepezil—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5.72e-05	0.00477	CbGpPWpGaD
Donepezil—Dizziness—Clonidine—glaucoma	5.72e-05	0.000234	CcSEcCtD
Donepezil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5.67e-05	0.00472	CbGpPWpGaD
Donepezil—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	5.65e-05	0.0047	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.61e-05	0.00467	CbGpPWpGaD
Donepezil—Musculoskeletal discomfort—Timolol—glaucoma	5.61e-05	0.00023	CcSEcCtD
Donepezil—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	5.6e-05	0.00466	CbGpPWpGaD
Donepezil—Insomnia—Timolol—glaucoma	5.57e-05	0.000228	CcSEcCtD
Donepezil—Hypersensitivity—Betaxolol—glaucoma	5.55e-05	0.000227	CcSEcCtD
Donepezil—Paraesthesia—Timolol—glaucoma	5.53e-05	0.000226	CcSEcCtD
Donepezil—Vomiting—Clonidine—glaucoma	5.5e-05	0.000225	CcSEcCtD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	5.5e-05	0.00458	CbGpPWpGaD
Donepezil—Dyspnoea—Timolol—glaucoma	5.49e-05	0.000225	CcSEcCtD
Donepezil—Somnolence—Timolol—glaucoma	5.47e-05	0.000224	CcSEcCtD
Donepezil—Rash—Clonidine—glaucoma	5.46e-05	0.000223	CcSEcCtD
Donepezil—Dermatitis—Clonidine—glaucoma	5.45e-05	0.000223	CcSEcCtD
Donepezil—Headache—Clonidine—glaucoma	5.42e-05	0.000222	CcSEcCtD
Donepezil—Dyspepsia—Timolol—glaucoma	5.42e-05	0.000222	CcSEcCtD
Donepezil—Asthenia—Betaxolol—glaucoma	5.41e-05	0.000221	CcSEcCtD
Donepezil—Decreased appetite—Timolol—glaucoma	5.35e-05	0.000219	CcSEcCtD
Donepezil—Pruritus—Betaxolol—glaucoma	5.33e-05	0.000218	CcSEcCtD
Donepezil—Gastrointestinal disorder—Timolol—glaucoma	5.31e-05	0.000218	CcSEcCtD
Donepezil—Fatigue—Timolol—glaucoma	5.31e-05	0.000217	CcSEcCtD
Donepezil—HTR2A—GPCR ligand binding—OPN4—glaucoma	5.3e-05	0.00441	CbGpPWpGaD
Donepezil—ACHE—Metabolism—NARFL—glaucoma	5.29e-05	0.0044	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CA5A—glaucoma	5.29e-05	0.0044	CbGpPWpGaD
Donepezil—Pain—Timolol—glaucoma	5.26e-05	0.000216	CcSEcCtD
Donepezil—Diarrhoea—Betaxolol—glaucoma	5.16e-05	0.000211	CcSEcCtD
Donepezil—Nausea—Clonidine—glaucoma	5.14e-05	0.000211	CcSEcCtD
Donepezil—Feeling abnormal—Timolol—glaucoma	5.07e-05	0.000208	CcSEcCtD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	5.05e-05	0.00421	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—NTRK2—glaucoma	5.04e-05	0.0042	CbGpPWpGaD
Donepezil—Gastrointestinal pain—Timolol—glaucoma	5.03e-05	0.000206	CcSEcCtD
Donepezil—Dizziness—Betaxolol—glaucoma	4.98e-05	0.000204	CcSEcCtD
Donepezil—Urticaria—Timolol—glaucoma	4.89e-05	0.0002	CcSEcCtD
Donepezil—Abdominal pain—Timolol—glaucoma	4.87e-05	0.000199	CcSEcCtD
Donepezil—Body temperature increased—Timolol—glaucoma	4.87e-05	0.000199	CcSEcCtD
Donepezil—HRH3—Signaling Pathways—OPN4—glaucoma	4.85e-05	0.00404	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—CTSA—glaucoma	4.85e-05	0.00404	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—EDN1—glaucoma	4.79e-05	0.00399	CbGpPWpGaD
Donepezil—Vomiting—Betaxolol—glaucoma	4.79e-05	0.000196	CcSEcCtD
Donepezil—HTR2A—GPCR ligand binding—PTGFR—glaucoma	4.77e-05	0.00397	CbGpPWpGaD
Donepezil—Rash—Betaxolol—glaucoma	4.75e-05	0.000195	CcSEcCtD
Donepezil—Dermatitis—Betaxolol—glaucoma	4.75e-05	0.000194	CcSEcCtD
Donepezil—Headache—Betaxolol—glaucoma	4.72e-05	0.000193	CcSEcCtD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	4.66e-05	0.00388	CbGpPWpGaD
Donepezil—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.64e-05	0.00386	CbGpPWpGaD
Donepezil—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	4.63e-05	0.00385	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	4.63e-05	0.00385	CbGpPWpGaD
Donepezil—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.6e-05	0.00383	CbGpPWpGaD
Donepezil—Hypersensitivity—Timolol—glaucoma	4.54e-05	0.000186	CcSEcCtD
Donepezil—HRH3—Signaling Pathways—HEYL—glaucoma	4.51e-05	0.00376	CbGpPWpGaD
Donepezil—Nausea—Betaxolol—glaucoma	4.48e-05	0.000183	CcSEcCtD
Donepezil—ACHE—Metabolism of proteins—ACE2—glaucoma	4.46e-05	0.00372	CbGpPWpGaD
Donepezil—Asthenia—Timolol—glaucoma	4.42e-05	0.000181	CcSEcCtD
Donepezil—HRH3—Signaling Pathways—PTGFR—glaucoma	4.37e-05	0.00364	CbGpPWpGaD
Donepezil—Pruritus—Timolol—glaucoma	4.36e-05	0.000178	CcSEcCtD
Donepezil—Diarrhoea—Timolol—glaucoma	4.21e-05	0.000172	CcSEcCtD
Donepezil—HRH3—GPCR ligand binding—C3—glaucoma	4.19e-05	0.00348	CbGpPWpGaD
Donepezil—Dizziness—Timolol—glaucoma	4.07e-05	0.000167	CcSEcCtD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	3.96e-05	0.0033	CbGpPWpGaD
Donepezil—Vomiting—Timolol—glaucoma	3.91e-05	0.00016	CcSEcCtD
Donepezil—Rash—Timolol—glaucoma	3.88e-05	0.000159	CcSEcCtD
Donepezil—Dermatitis—Timolol—glaucoma	3.88e-05	0.000159	CcSEcCtD
Donepezil—Headache—Timolol—glaucoma	3.86e-05	0.000158	CcSEcCtD
Donepezil—HTR2A—SIDS Susceptibility Pathways—BDNF—glaucoma	3.76e-05	0.00313	CbGpPWpGaD
Donepezil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	3.74e-05	0.00312	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—SMO—glaucoma	3.73e-05	0.0031	CbGpPWpGaD
Donepezil—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	3.69e-05	0.00307	CbGpPWpGaD
Donepezil—Nausea—Timolol—glaucoma	3.66e-05	0.00015	CcSEcCtD
Donepezil—HTR2A—SIDS Susceptibility Pathways—IL1A—glaucoma	3.61e-05	0.00301	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—RPTOR—glaucoma	3.42e-05	0.00285	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	3.39e-05	0.00282	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—NGF—glaucoma	3.34e-05	0.00278	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—NR3C1—glaucoma	3.33e-05	0.00277	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NCK2—glaucoma	3.31e-05	0.00276	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—EDN1—glaucoma	3.15e-05	0.00262	CbGpPWpGaD
Donepezil—CYP2D6—Biological oxidations—GSTT1—glaucoma	3.09e-05	0.00258	CbGpPWpGaD
Donepezil—CYP2C9—Biological oxidations—GSTT1—glaucoma	3.07e-05	0.00255	CbGpPWpGaD
Donepezil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	3.03e-05	0.00253	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—OPN4—glaucoma	2.99e-05	0.00249	CbGpPWpGaD
Donepezil—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	2.96e-05	0.00246	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HDAC9—glaucoma	2.82e-05	0.00234	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	2.81e-05	0.00234	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—OPN4—glaucoma	2.72e-05	0.00226	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—EDN1—glaucoma	2.71e-05	0.00225	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PTGFR—glaucoma	2.7e-05	0.00224	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CA1—glaucoma	2.58e-05	0.00215	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CTSA—glaucoma	2.5e-05	0.00208	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	2.49e-05	0.00207	CbGpPWpGaD
Donepezil—CYP2D6—Biological oxidations—CYP1B1—glaucoma	2.47e-05	0.00205	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—EDN1—glaucoma	2.46e-05	0.00205	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PTGFR—glaucoma	2.45e-05	0.00204	CbGpPWpGaD
Donepezil—CYP2C9—Biological oxidations—CYP1B1—glaucoma	2.44e-05	0.00203	CbGpPWpGaD
Donepezil—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	2.43e-05	0.00202	CbGpPWpGaD
Donepezil—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	2.41e-05	0.00201	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—SMO—glaucoma	2.41e-05	0.002	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—PAX6—glaucoma	2.38e-05	0.00198	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—C3—glaucoma	2.37e-05	0.00197	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CA2—glaucoma	2.36e-05	0.00197	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	2.36e-05	0.00196	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—LRP12—glaucoma	2.32e-05	0.00193	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.31e-05	0.00192	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.31e-05	0.00192	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.28e-05	0.0019	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—SMO—glaucoma	2.2e-05	0.00183	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NARFL—glaucoma	2.17e-05	0.0018	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CA5A—glaucoma	2.17e-05	0.0018	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CA5A—glaucoma	2.15e-05	0.00179	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NARFL—glaucoma	2.15e-05	0.00179	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—C3—glaucoma	2.15e-05	0.00179	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.08e-05	0.00173	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—GSTT1—glaucoma	2.02e-05	0.00168	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NTRK2—glaucoma	2.02e-05	0.00168	CbGpPWpGaD
Donepezil—CYP2D6—Biological oxidations—GSTM1—glaucoma	1.97e-05	0.00164	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.96e-05	0.00163	CbGpPWpGaD
Donepezil—CYP2C9—Biological oxidations—GSTM1—glaucoma	1.95e-05	0.00163	CbGpPWpGaD
Donepezil—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	1.94e-05	0.00162	CbGpPWpGaD
Donepezil—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	1.93e-05	0.0016	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.82e-05	0.00151	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NGFR—glaucoma	1.73e-05	0.00144	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.68e-05	0.0014	CbGpPWpGaD
Donepezil—ACHE—Metabolism—TXN—glaucoma	1.66e-05	0.00138	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NTRK1—glaucoma	1.64e-05	0.00137	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—CYP1B1—glaucoma	1.61e-05	0.00134	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—OPN4—glaucoma	1.61e-05	0.00134	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—VEGFA—glaucoma	1.6e-05	0.00133	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	1.59e-05	0.00132	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—EDN1—glaucoma	1.59e-05	0.00132	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.52e-05	0.00126	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CDKN2B—glaucoma	1.51e-05	0.00126	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.5e-05	0.00125	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HEYL—glaucoma	1.49e-05	0.00124	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.48e-05	0.00123	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—EDN1—glaucoma	1.45e-05	0.00121	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PTGFR—glaucoma	1.45e-05	0.0012	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NARFL—glaucoma	1.42e-05	0.00118	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CA5A—glaucoma	1.42e-05	0.00118	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—C3—glaucoma	1.39e-05	0.00115	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—TNF—glaucoma	1.37e-05	0.00114	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—MMP1—glaucoma	1.36e-05	0.00113	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NGF—glaucoma	1.33e-05	0.00111	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTT1—glaucoma	1.29e-05	0.00107	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.29e-05	0.00107	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.27e-05	0.00106	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—C3—glaucoma	1.27e-05	0.00106	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—SMO—glaucoma	1.23e-05	0.00103	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—APOE—glaucoma	1.18e-05	0.000983	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CAV1—glaucoma	1.17e-05	0.000974	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RPTOR—glaucoma	1.13e-05	0.000942	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—FN1—glaucoma	1.11e-05	0.000927	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—BAD—glaucoma	1.1e-05	0.000916	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NCK2—glaucoma	1.1e-05	0.000913	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CA1—glaucoma	1.06e-05	0.000881	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CA1—glaucoma	1.05e-05	0.000874	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—MMP2—glaucoma	1.05e-05	0.000873	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.04e-05	0.000866	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ABCA1—glaucoma	1.03e-05	0.000856	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CYP1B1—glaucoma	1.03e-05	0.000856	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CTSA—glaucoma	1.03e-05	0.000854	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CTSA—glaucoma	1.02e-05	0.000846	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CA2—glaucoma	9.68e-06	0.000806	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CA2—glaucoma	9.6e-06	0.000799	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	9.38e-06	0.000781	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	9.38e-06	0.000781	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HDAC9—glaucoma	9.32e-06	0.000776	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—EDN1—glaucoma	8.96e-06	0.000746	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NOS3—glaucoma	8.85e-06	0.000737	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTM1—glaucoma	8.22e-06	0.000684	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—EDN1—glaucoma	8.14e-06	0.000678	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—C3—glaucoma	7.83e-06	0.000652	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CDKN1B—glaucoma	7.67e-06	0.000638	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SMO—glaucoma	7.29e-06	0.000607	CbGpPWpGaD
Donepezil—ACHE—Metabolism—MTHFR—glaucoma	7.26e-06	0.000604	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—C3—glaucoma	7.11e-06	0.000592	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MMP9—glaucoma	7.1e-06	0.000591	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CA1—glaucoma	6.92e-06	0.000576	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—TXN—glaucoma	6.82e-06	0.000568	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—TXN—glaucoma	6.76e-06	0.000563	CbGpPWpGaD
Donepezil—ACHE—Metabolism—APOE—glaucoma	6.76e-06	0.000563	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CTSA—glaucoma	6.71e-06	0.000558	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CAV1—glaucoma	6.7e-06	0.000558	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NTRK2—glaucoma	6.67e-06	0.000555	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—VEGFA—glaucoma	6.38e-06	0.000531	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CA2—glaucoma	6.33e-06	0.000527	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	6.17e-06	0.000514	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	6.12e-06	0.000509	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NGFR—glaucoma	5.72e-06	0.000476	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NTRK1—glaucoma	5.44e-06	0.000453	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTT1—glaucoma	5.29e-06	0.00044	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTT1—glaucoma	5.25e-06	0.000437	CbGpPWpGaD
Donepezil—ACHE—Metabolism—NOS3—glaucoma	5.06e-06	0.000422	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CDKN2B—glaucoma	5.01e-06	0.000417	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TP53—glaucoma	4.82e-06	0.000401	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EDN1—glaucoma	4.81e-06	0.0004	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTGS2—glaucoma	4.63e-06	0.000386	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—TXN—glaucoma	4.46e-06	0.000371	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NGF—glaucoma	4.42e-06	0.000368	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.23e-06	0.000352	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP1B1—glaucoma	4.22e-06	0.000351	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ABCA1—glaucoma	4.22e-06	0.000351	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—C3—glaucoma	4.2e-06	0.00035	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ABCA1—glaucoma	4.18e-06	0.000348	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP1B1—glaucoma	4.18e-06	0.000348	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APOE—glaucoma	3.91e-06	0.000326	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CAV1—glaucoma	3.87e-06	0.000323	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FN1—glaucoma	3.69e-06	0.000307	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—BAD—glaucoma	3.64e-06	0.000303	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTT1—glaucoma	3.46e-06	0.000288	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTM1—glaucoma	3.37e-06	0.000281	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTM1—glaucoma	3.34e-06	0.000278	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—MTHFR—glaucoma	2.98e-06	0.000248	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—MTHFR—glaucoma	2.95e-06	0.000246	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NOS3—glaucoma	2.93e-06	0.000244	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APOE—glaucoma	2.77e-06	0.000231	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCA1—glaucoma	2.76e-06	0.000229	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP1B1—glaucoma	2.76e-06	0.000229	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APOE—glaucoma	2.75e-06	0.000229	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CAV1—glaucoma	2.75e-06	0.000229	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CAV1—glaucoma	2.72e-06	0.000227	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CDKN1B—glaucoma	2.54e-06	0.000211	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MMP9—glaucoma	2.35e-06	0.000196	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTM1—glaucoma	2.2e-06	0.000183	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—VEGFA—glaucoma	2.11e-06	0.000176	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NOS3—glaucoma	2.08e-06	0.000173	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NOS3—glaucoma	2.06e-06	0.000171	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—MTHFR—glaucoma	1.95e-06	0.000162	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTGS2—glaucoma	1.9e-06	0.000158	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTGS2—glaucoma	1.88e-06	0.000157	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOE—glaucoma	1.81e-06	0.000151	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CAV1—glaucoma	1.8e-06	0.00015	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TP53—glaucoma	1.59e-06	0.000133	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NOS3—glaucoma	1.36e-06	0.000113	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTGS2—glaucoma	1.24e-06	0.000103	CbGpPWpGaD
